Ironwood Pharmaceuticals Inc (IRWD)

Pharmaceutical Preparations

Latest Price

$3.50

TTM P/E

4.43

Normalized P/E

TTM Div Yield

Fwd Div Yield

Book Value

4.58

P/B Ratio

0.76

Valuation metrics

Norm. op. income: $120M (median of 7yr)

Tax rate: 31%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$4.00

+14% upside

Base FCF: $183M (median of recent 5yr)

Growth: 14%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$35.45

+913% upside

EPS: $0.15

Target P/E: 4×

Formula: EPS × P/E

P/E Fair Value

$0.60

83% downside

95.5% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	17.79M	$74.0M	10.77%	+4.43M	2026-06-30
Armistice Capital, LLC	13.93M	$58.0M	8.43%	-1.10M	2026-06-30
Sarissa Capital Management LP	9.19M	$38.0M	5.56%	--	2026-06-30
State Street Corp	8.81M	$37.0M	5.33%	+1.35M	2026-06-30
Bank of America Corp	8.68M	$36.0M	5.26%	+896	2026-06-30
Renaissance Technologies LLC	7.99M	$33.0M	4.84%	-67.8K	2026-06-30
Vanguard Capital Management LLC	6.61M	$27.0M	4.00%	+511.1K	2026-06-30
AQR Capital Management LLC	6.47M	$27.0M	3.91%	-1.07M	2026-06-30
Vanguard Portfolio Management LLC	5.51M	$23.0M	3.34%	-1.17M	2026-06-30
Geode Capital Management, LLC	4.83M	$20.0M	2.92%	+288.1K	2026-06-30